These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7875153)

  • 1. Potential role of granulocyte-macrophage colony-stimulating factor as vaccine adjuvant.
    Jones T; Stern A; Lin R
    Eur J Clin Microbiol Infect Dis; 1994; 13 Suppl 2():S47-53. PubMed ID: 7875153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines.
    Disis ML; Bernhard H; Shiota FM; Hand SL; Gralow JR; Huseby ES; Gillis S; Cheever MA
    Blood; 1996 Jul; 88(1):202-10. PubMed ID: 8704175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factor.
    Kumar S; Villinger F; Oakley M; Aguiar JC; Jones TR; Hedstrom RC; Gowda K; Chute J; Stowers A; Kaslow DC; Thomas EK; Tine J; Klinman D; Hoffman SL; Weiss WW
    Immunol Lett; 2002 Apr; 81(1):13-24. PubMed ID: 11841841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
    Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
    Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease.
    Fabrizi F; Ganeshan SV; Dixit V; Martin P
    Aliment Pharmacol Ther; 2006 Sep; 24(5):789-96. PubMed ID: 16918882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of the role of granulocyte-macrophage colony-stimulating factor in animals and man from in vitro results.
    Liehl E; Hildebrandt J; Lam C; Mayer P
    Eur J Clin Microbiol Infect Dis; 1994; 13 Suppl 2():S9-17. PubMed ID: 7875154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor.
    Zhai Y; Zhou Y; Li X; Feng G
    Mol Med Rep; 2015 Jul; 12(1):199-209. PubMed ID: 25738258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine.
    Tarr PE; Lin R; Mueller EA; Kovarik JM; Guillaume M; Jones TC
    Vaccine; 1996 Sep; 14(13):1199-204. PubMed ID: 8961505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-macrophage colony-stimulating factor, a potent adjuvant for polarization to Th-17 pattern: an experience on HIV-1 vaccine model.
    Mahdavi M; Tajik AH; Ebtekar M; Rahimi R; Adibzadeh MM; Moozarmpour HR; Beikverdi MS; Olfat S; Hassan ZM; Choopani M; Kameli M; Hartoonian C
    APMIS; 2017 Jun; 125(6):596-603. PubMed ID: 28493367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogel-delivered GM-CSF overcomes nonresponsiveness to hepatitis B vaccine through the recruitment and activation of dendritic cells.
    Chou HY; Lin XZ; Pan WY; Wu PY; Chang CM; Lin TY; Shen HH; Tao MH
    J Immunol; 2010 Nov; 185(9):5468-75. PubMed ID: 20889541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection.
    Sasaki Md; Foccacia R; de Messias-Reason IJ
    Vaccine; 2003 Nov; 21(31):4545-9. PubMed ID: 14575766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines.
    Chang DZ; Lomazow W; Joy Somberg C; Stan R; Perales MA
    Hematology; 2004 Jun; 9(3):207-15. PubMed ID: 15204102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders.
    Jha R; Lakhtakia S; Jaleel MA; Narayan G; Hemlatha K
    Ren Fail; 2001 Sep; 23(5):629-36. PubMed ID: 11725909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoviral-expressed recombinant granulocyte monocyte colony-stimulating factor (GM-CSF) enhances protective immunity induced by inactivated Newcastle Disease Virus (NDV) vaccine.
    Wang X; Wang X; Jia Y; Wang C; Han Q; Lu ZH; Yang Z
    Antiviral Res; 2017 Aug; 144():322-329. PubMed ID: 28698014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine GM-CSF genetic adjuvant facilitates prophylactic DNA vaccine against pseudorabies virus through enhanced immune responses.
    Yoon HA; Aleyas AG; George JA; Park SO; Han YW; Lee JH; Cho JG; Eo SK
    Microbiol Immunol; 2006; 50(2):83-92. PubMed ID: 16490926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD45 cell surface antigens are linked to stimulation of early human myeloid progenitor cells by interleukin 3 (IL-3), granulocyte/macrophage colony-stimulating factor (GM-CSF), a GM-CSF/IL-3 fusion protein, and mast cell growth factor (a c-kit ligand).
    Broxmeyer HE; Lu L; Hangoc G; Cooper S; Hendrie PC; Ledbetter JA; Xiao M; Williams DE; Shen FW
    J Exp Med; 1991 Aug; 174(2):447-58. PubMed ID: 1713254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and characterization of a chimeric fusion protein consisting of an anti-idiotype antibody mimicking a breast cancer-associated antigen and the cytokine GM-CSF.
    Tripathi PK; Qin H; Bhattacharya-Chatterjee M; Ceriani RL; Foon KA; Chatterjee SK
    Hybridoma; 1999 Apr; 18(2):193-202. PubMed ID: 10380019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
    Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
    Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.